Additional file 2 of EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell lines
Supplementary Material 2: Supplementary Figure 1: Induction of Regorafenib resistance by EPHX1 in hepatocarcinoma cell lines. (A) The IC50 values of Regorafenib were detected by CCK-8 assays in four HCC cell lines. (B) Western blot analysis showed the levels of EPHX1 in four HCC cell lines after Regorafenib treatment. * p < 0.05，** p < 0.01，*** p < 0.001.
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- Figshare
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6084/m9.figshare.29755813
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00